Health Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as th...
AbbVie has entered a partnership and option-to-license agreement with Xilio for ...
The funding will be used to complete the Phase II/III trial of ulviprubart, and ...
GlobalData’s Revati Tatake discussed key trends in biopharma which are set to ha...
Lundbeck has received the US FDA fast track designation for amlenetug, a potenti...
Merck acquisition target SpringWorks will go toe-to-toe with AstraZeneca in the ...
Travere’s stock price climbed by 14% following the announcement it will seek an ...
EC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under th...
Health Canada has approved MSD's Keytruda for treating adults with resectable st...
Trump's tariffs will not only impact sponsors, but higher costs will ripple down...
China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of St...
Tim Andrews underwent the procedure with the pig kidney as part of a three-perso...
Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in ...
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desm...
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with ...
